P

Inventor

ELKON KEITH

US13 patents
⚠️ This page may combine multiple inventors who share the name “ELKON KEITH”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

UNIV WASHINGTON

7 patents
US10000745B2Jun 19, 2018

Therapeutic nuclease compositions and methods

UNIV WASHINGTON12 citations92
US8937157B2Jan 20, 2015

Therapeutic nuclease compositions and methods

UNIV WASHINGTON24 citations92
US11306297B2Apr 19, 2022

Therapeutic nuclease compositions and methods

UNIV WASHINGTON7 citations85
US11034944B2Jun 15, 2021

Therapeutic nuclease compositions and methods

UNIV WASHINGTON4 citations83
US9790479B2Oct 17, 2017

Therapeutic nuclease compositions and methods

UNIV WASHINGTON9 citations83
US12338466B2Jun 24, 2025

Therapeutic nuclease compositions and methods

UNIV WASHINGTON0 citations62
US10329258B2Jun 25, 2019

CGAS in systemic lupus erythematosus (SLE)

UNIV WASHINGTON0 citations44

LEDBETTER JEFFREY A

2 patents
US8841416B2Sep 23, 2014

Therapeutic nuclease compositions and methods

LEDBETTER JEFFREY A34 citations97
US10202588B2Feb 12, 2019

Therapeutic nuclease compositions and methods

LEDBETTER JEFFREY A9 citations83

HOFFMANN LA ROCHE

1 patent
US4865970ASep 12, 1989

Method of detecting ribosomal protein antibodies in systemic lupus erythematosus

HOFFMANN LA ROCHE30 citations90

KAESERMANN FABIAN

1 patent
US8632773B2Jan 21, 2014

Antibody composition with altered Fab sialylation

KAESERMANN FABIAN20 citations83

CORNELL RES FOUNDATION INC

1 patent
US6525029B1Feb 25, 2003

Method of inhibiting and immune response to a recombinant vector

CORNELL RES FOUNDATION INC13 citations82

UNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION

1 patent
US12435322B2Oct 7, 2025

Therapeutic nuclease compositions and methods

UNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION0 citations62